Skip to main content
SpringerLink
Log in

Diabetes

  • Living reference work entry
  • First Online:
Geriatric Medicine

  • 30 Accesses

Abstract

Older adults with diabetes are a heterogeneous population in terms of comorbidities, functional ability, mental health and psychosocial issues, support system, location of care, staff competencies, and practitioner preferences. Hence, the care of these individuals is challenging and requires an individualized, creative, and person-centered approach. A systematic and careful evaluation of their health and comorbidities, diabetes self-management skills, hypoglycemia risk, mobility, cognitive and functional status, and affordability of medications is recommended. Over time, medical complexity will increase, with the background of concurrent geriatric syndromes and frailty. Older adults with diabetes are likely to experience one or more care transitions and may eventually need thoughtful discussions for planning care at the end of life. The authors will also discuss a case-based approach to medication management, glycemic goals, avoidance of hypoglycemia, and improving care transitions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Abd El Aziz MS, Kahle M, Meier JJ, Nauck MA. A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients. Diabetes Obes Metab. 2017;19:216–27.

    CAS  PubMed  Google Scholar 

  2. ACCORD. The action to control cardiovascular risk in diabetes study group. N Engl J Med. 2008;358:2545–59. https://doi.org/10.1056/NEJMoa0802743.

    Article  Google Scholar 

  3. Adam JM, Tarigan NP. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening. Acta Med Indones. 2004;36(1):3–7.

    PubMed  Google Scholar 

  4. Afilalo J, Karunananthan S, Eisenberg MJ, et al. Role of frailty in patients with cardiovascular disease. Am J Cardiol. 2009;103:1616–21.

    PubMed  Google Scholar 

  5. American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care 2018; dci180007. https://doi.org/10.2337/dci18-0007

  6. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021, American Diabetes Association, Diabetes Care. 2021;44 (Supplement 1):S15–S33. https://doi.org/10.2337/dc21-S002

  7. Older Adults: Standards of Medical Care in Diabetes—2021, American Diabetes Association, Diabetes Care 2021;44(Supplement 1):S168–S179. https://doi.org/10.2337/dc21-S012

  8. American Diabetes Association. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2020. Diabetes Care. 2020;43(Supplement 1):S98–S110. https://doi.org/10.2337/dc20-S009.

    Article  Google Scholar 

  9. American Diabetes Association. Diabetes technology: standards of medical care in diabetes – 2020. Diabetes Care. 2020;43(Supplement 1):S77–88. https://doi.org/10.2337/dc20-S007.

    Article  Google Scholar 

  10. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616–31.

    Google Scholar 

  11. American Medical Directors Association. AMDA clinical practice guideline: diabetes management in the post-acute and long-term care setting. American Medical Directors Association: Columbia; 2015.

    Google Scholar 

  12. Angelo M, Ruchalski C, Sproge BJ. An approach to diabetes mellitus in hospice and palliative medicine. J Palliat Med. 2011;14:83–7.

    PubMed  Google Scholar 

  13. Aronson R, Cohen O, Conget I, et al. OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods. Diabetes Technol Ther. 2014;16(7):414–20.

    CAS  PubMed  Google Scholar 

  14. Azoulay L, Suissa S. Sulfonylureas and the risks of cardiovascular events and death A methodical Meta-Regression analysis of the observational studies. Diabetes Care. 2017;40(5):706–14.

    CAS  PubMed  Google Scholar 

  15. Bajwa SJ, Sehgal V, Kalra S, Baruah MP. Management of diabetes mellitus type-2 in the geriatric population: current perspectives. J Pharm Bioallied Sci. 2014;6(3):151. https://doi.org/10.4103/0975-7406.130956.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Bhatt, D et al. REDUCE-IT Investigators N Engl J Med 2019;380:11–22.

    Google Scholar 

  17. Blaum C, Cigolle CT, Boyd C, et al. Clinical complexity in middle-aged and older adults with diabetes: the health and retirement study. Med Care. 2010;48(4):327–34.

    PubMed  PubMed Central  Google Scholar 

  18. Bodmer M, et al. Metformin, Sulfonylureas or other antidiabetic drugs and the risk of lactic acidosis or hypoglycemia. Diabetes Care. 2008;31(11):2086–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ. 2016;352:i717.

    PubMed  PubMed Central  Google Scholar 

  20. C Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes, List of authors.The ACCORD Study Group, N Engl J Med 2011;364:818–828. https://doi.org/10.1056/NEJMoa1006524

  21. Cadore EL, Izquierdo M. Exercise interventions in polypathological aging patients that coexist with diabetes mellitus: improving functional status and quality of life. Age (Dordr). 2015;37:64. https://doi.org/10.1007/s11357-015-9800-2.

    Article  CAS  Google Scholar 

  22. Cersosimo E, Lee PG, Pandya N. Challenges of diabetes care in older people with Type 2 diabetes and the role of basal insulin. Clin Diabetes. 2019;37(4):357–67. https://doi.org/10.2337/cd18-0074.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Chau D, Edelman SV. Clinical MANAGEMENT of diabetes in the elderly. Clin Diabetes. 2001;19(4):172–5. https://doi.org/10.2337/diaclin.19.4.172.

    Article  Google Scholar 

  24. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Cholesterol Treatment Trialists’ Collaboration. Lancet 2019;393(10170):407–415.

    Google Scholar 

  25. Cigolle CT, Kabeto MU, Lee PG, Blaum CS. Clinical complexity and mortality in middle-aged and older adults with diabetes. J Gerontol A Biol Sci Med Sci. 2012;67(12):1313–20.

    PubMed  PubMed Central  Google Scholar 

  26. Collaborative overview of randomized trials of antiplatelet therapy—I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists’ Collaboration. BMJ 1994;308: 81–106.

    Google Scholar 

  27. Collins R, Armitage J, Parish S, Heart Protection Study Collaborative Group, et al. Heart Protection Study of cholesterol lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005–16.

    PubMed  Google Scholar 

  28. Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304:61–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 2010; 375: pp. 481-489 with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481–9.

    CAS  PubMed  Google Scholar 

  30. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F, The ACCORD study group. Effects of intensive blood pressure control in Type 2 DM. N Engl J Med. 2010;362:1575–85. https://doi.org/10.1056/NEJMoa1001286.

    Article  CAS  PubMed  Google Scholar 

  31. Custódio JS, Roriz-Filho J, Cavalcanti CAJ, et al. Use of SGLT2 inhibitors in older adults: scientific evidence and practical aspects. Drugs Aging. 2020;37:399–409.

    PubMed  Google Scholar 

  32. Dormandy JA, Charbonnel B, Eckland DJA, Erdmann E, PROactive study. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366(9493):1279–89. https://doi.org/10.1016/S0140-6736(05)67528-9.

    Article  CAS  PubMed  Google Scholar 

  33. Dorner B, Friedrich EK, Posthauer ME. Practice paper of the American Dietetic Association: individualized nutrition approaches for older adults in health care communities. J Am Diet Assoc. 2010;110:1554–63.

    PubMed  Google Scholar 

  34. Einarson TR, Acs A, Ludwig C, et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17:83.

    PubMed  PubMed Central  Google Scholar 

  35. Feinkohl I, Aung PP, Keller M, Edinburgh Type 2 Diabetes Study (ET2DS) Investigators, et al. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care. 2014;37:507–15.

    CAS  PubMed  Google Scholar 

  36. Forbes A, Murrells T, Mulnier H, Sinclair AJ. Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6(6):476–86.

    PubMed  Google Scholar 

  37. Garber AJ, Handelsman Y, Grunberger G, Einhorn D, Abrahamson MJ, Barzilay JI, Blonde L, Bush MA, DeFronzo RA, Garber JR, Garvey WT, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Perreault L, Rosenblit PD, Samson S, Umpierrez GE. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2020 EXECUTIVE SUMMARY. Endocr Pract. 2020;26(1):1.

    Google Scholar 

  38. Hartmann-Boyce J, Morris E, Goyder C, Kinton J, Perring J, Nunan D, Mahtani K, Buse JB, Del Prato S, Ji L, Roussel R, Khunti K. Diabetes and COVID-19: risks, management, and learnings from other national disasters. Diabetes Care. 2020;43(8):1695–703. https://doi.org/10.2337/dc20-1192.

    Article  CAS  PubMed  Google Scholar 

  39. Hermida RC, Ayala DE, Mojón A, Fernández JR. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 2011;34:1270–6.

    PubMed  PubMed Central  Google Scholar 

  40. Hewston P, Deshpande N. Falls and balance impairments in older adults with Type 2 diabetes: thinking beyond diabetic peripheral neuropathy RSS. Can J Diabetes. 2016;40(1):6–9.

    PubMed  Google Scholar 

  41. Holstein A, Hammer C, Hahn M, Kulamadayil N-S-A, Kovacs P. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert Opin Drug Saf. 2010;9(5):675–81. https://doi.org/10.1517/14740338.2010.492777.

    Article  CAS  PubMed  Google Scholar 

  42. Huang ES, Liu JY, Moffet HH, John PM, Karter AJ. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care. 2011;34(6):1329–36.

    PubMed  PubMed Central  Google Scholar 

  43. Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2014;174(2):251–8. https://doi.org/10.1001/jamainternmed.2013.12956.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Kalyani RR, Metter EJ, Egan J, et al. Hyperglycemia predicts persistently lower muscle strength with aging. Diabetes Care. 2015;38:82–90.

    PubMed  Google Scholar 

  45. Kelsey S, et al. An overview of GLP-1 agonists and recent cardiovascular outcome trials. BMJ. 96(1133):156–61.

    Google Scholar 

  46. Khalse M, Bhargava A. A review of cardiovascular outcome studies of Dipeptidyl Peptidase-4 Inhibitors. Indian J Endocrinol Metab. 2018;22(5):689–95.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care. 2012;35:2650–64.

    PubMed  PubMed Central  Google Scholar 

  48. Ledesma G, Umpierrez GE, Morley JE, et al. Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: a randomized trial. Diabetes Obes Metab. 2019;21:2465–73.

    CAS  PubMed  Google Scholar 

  49. Lee S, Lee S, Harada K, et al. Relationship between chronic kidney disease with diabetes or hypertension and frailty in community-dwelling Japanese older adults. Geriatr Gerontol Int. 2017a;17:1527–33.

    PubMed  Google Scholar 

  50. Lee AK, Lee CJ, Huang ES, Sharrett AR, Coresh J, Selvin E. Risk factors for severe hypoglycemia in black and white adults with diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2017b;40:1661–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Lipska KJ, Inzucchi SE, Van Ness PH, Gill TM, Kanaya A, Strotmeyer ES, Koster A, Johnson KC, Goodpaster BH, Harris T, De Rekeneire N, for the Health ABC Study. Elevated HbA1c and fasting plasma glucose in predicting diabetes incidence among older adults. Diabetes Care. 2013;36(12):3923–9. https://doi.org/10.2337/dc12-2631.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Mallery LH, Ransom T, Steeves B, Cook B, Dunbar P, Moorhouse P. Evidence-informed guidelines for treating frail older adults with type 2 diabetes: from the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) program. J Am Med Dir Assoc. 2013;14:801–8.

    PubMed  Google Scholar 

  53. Maruthur NM, Tseng E, Hutfless S, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2016;164:740–75.

    PubMed  Google Scholar 

  54. Mate KS, Berman A, Laderman M, Kabcenell A, Fulmer T. Creating age-friendly health systems – a vision for better care of older adults. Healthcare. 2018;6(1):4–6., ISSN 2213-0764. https://doi.org/10.1016/j.hjdsi.2017.05.005.

    Article  PubMed  Google Scholar 

  55. McNeil JJ, Wolfe R, Woods RL, et al. ASPREE Investigator Group. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018;379:1509–18.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Meneilly GS, Tessier D. Diabetes in the elderly. In: Morley JE, van den Berg L, editors. Contemporary endocrinology, Endocrinology of aging. Totowa: Humana Press; 2000. p. 181–203.

    Google Scholar 

  57. Meneilly GS, Tessier D. Diabetes in elderly adults. J Gerontol Series A. 2001;56(1):M5–M13. https://doi.org/10.1093/gerona/56.1.M5.

    Article  CAS  Google Scholar 

  58. Migdal A, Yarandi SS, Smiley D, Umpierrez GE. Update on diabetes in the elderly and in nursing home residents. J Am Med Dir Assoc. 2011;12:627–632.e2.

    PubMed  Google Scholar 

  59. Munshi MN. Cognitive dysfunction in older adults with diabetes: what a clinician needs to know. Diabetes Care. 2017;40(4):461–7. https://doi.org/10.2337/dc16-1229.

    Article  CAS  PubMed  Google Scholar 

  60. Munshi MN, Segal AR, Suhl E, et al. Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med. 2011;171:362–36.

    PubMed  PubMed Central  Google Scholar 

  61. Munshi MN, Florez H, Huang ES, et al. Management of diabetes in long-term care and skilled nursing facilities: a position statement of the American Diabetes Association. Diabetes Care. 2016a;39:308–18.

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Munshi MN, Slyne C, Segal AR, Saul N, Lyons C, Weinger K. Simplification of insulin regimen in older adults and risk of hypoglycemia. JAMA Intern Med. 2016b;176:1023–5.

    PubMed  Google Scholar 

  63. National Diabetes Statistics Report. 2020. http://www.cdc.gov/diabetes.

  64. Neil HAW, DeMicco DA, Luo D, et al. Analysis of efficacy and safety in patients aged 65–75 years at randomisation. Collaborative Atorvastatin Diabetes Study (CARDS). Diabetes Care. 2006;29:2378–84.

    CAS  PubMed  Google Scholar 

  65. Orchard TJ, Secrest AM, Miller RG, Costacou T. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia. 2010;53(11):2312–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  66. Pandya N, Losben N, Moore J. Optimizing insulin delivery for patients with diabetes. Geriatr Nurs. 2018;39:138–42.

    PubMed  Google Scholar 

  67. Pandya N, Hames E, Sandhu S. Challenges and strategies for managing diabetes in the elderly in long-term care settings. Diabetes Spectrum. 2020;33(3):236–45. https://doi.org/10.2337/ds20-0018.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Pohl M, Mayr P, Mertl-Roetzer M, et al. Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial. JPEN J Parenter Enteral Nutr. 2009;33:37–49.

    CAS  PubMed  Google Scholar 

  69. Rodriguez-Mañas L, Laosa O, Vellas B, et al. European MID-Frail Consortium. Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus. J Cachexia Sarcopenia Muscle. 2019;10:721–33.

    PubMed  PubMed Central  Google Scholar 

  70. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010:CD002967.

    Google Scholar 

  71. Schroeder E, et al. The longitudinal relationship between food and insecurity in older adults with diabetes and ED visits, hospitalizations, HBA1C and medication adherence. J Diabetes Complicat. 2019;33:289–95.

    Google Scholar 

  72. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623–30.

    CAS  PubMed  Google Scholar 

  73. Sinclair AJ, Abdelhafiz AH. Challenges and strategies for diabetes management in community-living older adults. Diabetes Spectrum. 2020;33(3):217–27. https://doi.org/10.2337/ds20-0013.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Tessier DM, Meneilly GS, Moleski L, Trottier L, Lanthier L. Influence of blood pressure and other clinical variables on long-term mortality in a cohort of elderly subjects with Type 2 diabetes. Can J Diabetes. 2016;40(1):12–6.

    PubMed  Google Scholar 

  75. Tewary S, Pandya N, Cook NJ. Diabetes foot education: an evidence based study in long term care settings. Annals of Long-Term Care. 2014:329.

    Google Scholar 

  76. Trends in the Causes of Older Persons in the United States. http://www.cdc.gov/nchs/data/ahcd/06olderpersons

  77. Umpierrez GE, Pasquel FJ. Management of inpatient hyperglycemia and diabetes in older adults. Diabetes Care. 2017;40:509–17.

    PubMed  PubMed Central  Google Scholar 

  78. Unnikrishnan R, Anjana RM, Mohan V. Drugs affecting HbA1c levels. Indian J Endocrinol Metab. 2012;16(4):528–31. https://doi.org/10.4103/2230-8210.98004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Vue MH, Setter SM. Drug-induced glucose alterations part 1: drug-induced hypoglycemia. Diabetes Spectrum. 2011;24(3):171–7. https://doi.org/10.2337/diaspect.24.3.171.

    Article  Google Scholar 

  80. Weinstock RS, DuBose SN, Bergenstal RM, et al. T1D exchange severe hypoglycemia in older adults with type 1 diabetes study group. Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes. Diabetes Care. 2016;39:603–10.

    CAS  PubMed  Google Scholar 

  81. Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years. A randomized clinical trial. JAMA. 2016;315:2673–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  82. Yoon JW, Ha YC, Kim KM, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean Longitudinal Study on Health and Aging. Diabetes Metab J. 2016;40:140–6.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL, USA

    Naushira Pandya

  2. Department of Geriatrics, Wright State University Boonshoft School of Medicine, Dayton, OH, USA

    Meenakshi Patel

Authors
  1. Naushira Pandya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meenakshi Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naushira Pandya .

Editor information

Editors and Affiliations

  1. Rockport Healthcare Services, Woodland Hills, CA, USA

    Michael Wasserman

  2. Betty Irene Moore School of Nursing, University of California, Davis, Sacramento, CA, USA

    Debra Bakerjian

  3. Department of Clinical Pharmacy, University of Colorado, Aurora, CO, USA

    Sunny Linnebur

  4. Division of Geriatrics, SUNY Upstate Medical University, Syracuse, NY, USA

    Sharon Brangman

  5. Alliant GMCF, Atlanta, GA, USA

    Adrienne Mims

  6. Division of Geriatric Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Jerry C. Johnson

Section Editor information

  1. California Association of Long Term Care Medicine, Newbury Park, California, USA

    Michael R. Wasserman

  2. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

    Matteo Cesari

  3. Geriatric Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

    Matteo Cesari

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Pandya, N., Patel, M. (2021). Diabetes. In: Wasserman, M., Bakerjian, D., Linnebur, S., Brangman, S., Mims, A., Johnson, J.C. (eds) Geriatric Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-01782-8_38-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-01782-8_38-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-01782-8

  • Online ISBN: 978-3-030-01782-8

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation